Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Svedbom

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|July 15, 2018
The long-term impact of multiple sclerosis on the risk of divorceErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Sick leave and disability pension before and after diagnosis of multiple sclerosisErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Acta Dermato-Venereologica|January 3, 2025
Assessing the Comorbidity Cycle Between Psoriasis and Addiction Based on ICD Coding in the Stockholm Psoriasis CohortHannah Wecker, Axel Svedbom, Fabio Sánchez Orrego, et al.
Journal of Neurology|February 3, 2018
The long-term impact of early treatment of multiple sclerosis on the risk of disability pensionErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Patient Preference and Adherence|February 29, 2020
Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature ReviewKarin Luttropp, Johan Dalén, Axel Svedbom, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Personal Income Before and After Diagnosis of Multiple SclerosisErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Acta Dermato-Venereologica|November 15, 2024
Risk Factors Associated with Weight Gain during Treatment with Dupilumab among Patients with Moderate to Severe Atopic DermatitisMahsa Tayefi, Axel Svedbom, Lina Ivert, et al.
Acta Dermato-Venereologica|October 4, 2022
The Impact of Systemic Treatment of Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort StudyLina U Ivert, Axel Svedbom, Maria Lundqvist, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 16, 2019
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitisAxel Svedbom, Johan Dalén, Moa Ivergård, et al.
Acta Dermato-Venereologica|December 31, 2015
Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register AnalysisAxel Svedbom, Johan Dahlén, Carla Mamolo, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|July 15, 2018
The long-term impact of multiple sclerosis on the risk of divorceErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Sick leave and disability pension before and after diagnosis of multiple sclerosisErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Acta Dermato-Venereologica|January 3, 2025
Assessing the Comorbidity Cycle Between Psoriasis and Addiction Based on ICD Coding in the Stockholm Psoriasis CohortHannah Wecker, Axel Svedbom, Fabio Sánchez Orrego, et al.
Journal of Neurology|February 3, 2018
The long-term impact of early treatment of multiple sclerosis on the risk of disability pensionErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Patient Preference and Adherence|February 29, 2020
Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature ReviewKarin Luttropp, Johan Dalén, Axel Svedbom, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Personal Income Before and After Diagnosis of Multiple SclerosisErik Landfeldt, Anna Castelo-Branco, Axel Svedbom, et al.
Acta Dermato-Venereologica|November 15, 2024
Risk Factors Associated with Weight Gain during Treatment with Dupilumab among Patients with Moderate to Severe Atopic DermatitisMahsa Tayefi, Axel Svedbom, Lina Ivert, et al.
Acta Dermato-Venereologica|October 4, 2022
The Impact of Systemic Treatment of Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort StudyLina U Ivert, Axel Svedbom, Maria Lundqvist, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 16, 2019
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitisAxel Svedbom, Johan Dalén, Moa Ivergård, et al.
Acta Dermato-Venereologica|December 31, 2015
Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register AnalysisAxel Svedbom, Johan Dahlén, Carla Mamolo, et al.
Pageof 5